Anti-aging composition and application thereof

By combining fermented ginseng and selenium-rich yeast in anti-aging products and adding other ingredients to optimize the formula, the problems of low activity and complex preparation in existing products are solved, and stronger anti-aging effects and applicability are achieved, especially Targeting the needs of the elderly.

CN119014535APending Publication Date: 2024-11-26ANGEL NUTRITECH CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202310599411.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-25
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The active ingredients of ginseng extract in existing anti-aging products have low biological activity and are difficult to absorb, and the preparation process is complex and costly. They cannot effectively convert rare ginseng saponins and have poor applicability, especially for the elderly.

Method used

Develop an anti-aging composition containing fermented ginseng and selenium-rich yeast, and combines other ingredients such as yeast polypeptides, NMN, PQQ, etc. to optimize the component ratio and formula, improve the content and type distribution of rare ginseng saponins, and enhance the anti-aging effect.

Benefits of technology

The composition enhances cell phagocytosis and antioxidant functions, improves mitochondrial function damage, reduces wrinkles and brown spots, has good anti-aging effects, and is suitable for different populations, including the elderly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004251489280000121
    Figure BDA0004251489280000121
  • Figure BDA0004251489280000151
    Figure BDA0004251489280000151
Patent Text Reader

Abstract

The invention provides an anti-aging composition and application thereof, the anti-aging composition at least contains two active ingredients of fermented ginseng and selenium-enriched yeast, the weight percentage content of the fermented ginseng in the anti-aging composition is 1%-98%, the weight percentage content of the selenium-enriched yeast in the anti-aging composition is 0.1%-90%, and the weight percentage content of the selenium-enriched yeast in the anti-aging composition is 0.1%-90%. The total content of the fermented ginseng and the selenium-enriched yeast is less than or equal to 100%. The composition not only has a very good prevention effect on internal aging of a body, but also has a certain prevention effect on skin aging, and can increase the content of collagen fibers in skin, reduce wrinkles and brown spots and improve skin microcirculation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of health food, and in particular relates to an anti-aging composition and application thereof. Background Art

[0002] Aging is a complex and inevitable biological process. When the body's functional organs mature, signs of aging begin to appear. Over time, changes such as stem cell failure, mitochondrial dysfunction, impaired immune function, reduced autophagy, epigenetic changes, accumulation of somatic and mitochondrial DNA mutations, abnormal intercellular communication, and telomere loss occur. According to the "World Population Prospects 2019" released by the United Nations: China's aging rate is expected to be 26.1% by 2050, ranking 33rd in the world. Therefore, the research on products to prevent aging has important social and practical significance.

[0003] Modern pharmacological studies have shown that ginsenosides have anti-aging, neuroprotective, immune-enhancing and anti-inflammatory effects. Fermented ginseng is a product obtained by multi-stage fermentation of ginseng by microorganisms after crushing it. The glycosidic bonds of ginsenosides are broken under the action of microorganisms, and the less active ginsenosides are converted into highly active rare ginsenosides, which enhances the anti-aging effects of ginsenosides. Animal experiments have shown that ginsenoside Rg1 can significantly reduce the percentage of positive cells for β-galactosidase and the content of advanced glycation end products (AGEs). In addition, studies have found that ginsenoside Rg1 can reduce the expression level of aging-related proteins in splenocytes and thymocytes, delay the aging of immune cells, and improve the function of immune organs. Ginsenosides Rg3 and Rb1 have the effects of anti-oxidation and prevention of neurodegenerative lesions during aging. Ginsenoside Rg3 can also inhibit the release of cytochrome c from mitochondria, inhibit cell apoptosis, restore mitochondrial adenosine triphosphate (ATP) and membrane potential, and protect mitochondria. In addition, ginsenosides have the effects of delaying the aging of immune organs, enhancing cell phagocytosis, promoting the differentiation and proliferation of immune cells, and thus improving immunity.

[0004] Selenium-enriched yeast is a biological preparation developed using bioengineering technology that can enrich the trace element selenium. During the fermentation process of yeast, yeast can organically combine its own proteins or polysaccharides with inorganic selenium through growth metabolism, converting inorganic selenium into organic selenium, greatly improving the bioavailability of selenium. Selenium plays an important role in delaying the aging process and improving the health of the elderly. Free radicals and lipid peroxidation are the main factors that cause membrane damage and promote the aging process. Selenium-containing enzyme glutathione peroxidase (GSH-Px) is the most important antioxidant enzyme in the body. It can maintain the normal physiological functions of cells and tissues by removing selenoproteins of active oxygen, reducing peroxides to harmless water or alcohol, and eliminating peroxidized lipids, reducing the adverse effects of free radicals on the body, and playing a role in delaying aging. Animal experiments have shown that selenium supplementation can effectively improve the antioxidant capacity of D-galactose-induced aging mouse models, and plays an important role in preventing neurological damage and preventing brain cell aging.

[0005] In addition to being rich in ginsenosides, peptides, amino acids and various organic acids, fermented ginseng also contains bacterial lysis and metabolites. Various substances have diverse functions. In addition to protecting mitochondrial function, inhibiting tumors and enhancing cell phagocytosis, they can also regulate intestinal health, resist fatigue and relieve insomnia symptoms. The intake of selenium-enriched yeast can increase the activity of antioxidant enzymes, thereby preventing the accumulation of free radicals in the body. In addition, selenium also protects the liver and reduces the formation of brown spots. Summary of the invention

[0006] Most of the existing anti-aging products compound ginseng extract with other functional ingredients, or ferment ginseng extract with yeast or the like to make fermented food, beverage or wine. On the one hand, in anti-aging products that compound ginseng extract with other functional ingredients, the active ingredients of ginseng extract are mostly inherent ginsenosides, which have low biological activity, are difficult to absorb, and have limited anti-aging effects. On the other hand, the method of fermenting ginseng extract with yeast or the like to make fermented food, beverage or wine has a relatively complicated preparation process and high cost, and the efficiency of converting rare ginsenosides and the dissolution rate of rare ginsenosides in this method are not high, and some products have poor applicability and cannot be used for special populations such as the elderly.

[0007] Therefore, there is an urgent need to further develop products with higher content of rare ginsenosides, more comprehensive types of ginsenosides, more scientific content distribution, and stronger anti-aging effects.

[0008] In view of this, in order to solve the problems and defects of the prior art, the present invention provides an anti-aging composition and its application. The composition can enhance cell phagocytosis and the body's own antioxidant function, has a good repair effect on the body's oxidative damage, can also downregulate inflammatory factors, has a certain improvement effect on mitochondrial function damage and skin aging caused by aging, can increase the skin collagen fiber content, reduce wrinkles and brown spots, and has anti-aging ability.

[0009] In order to solve the above-mentioned existing technical problems, the technical solutions adopted in this application are as follows:

[0010] In a first aspect, the present invention provides an anti-aging composition, which contains at least two active ingredients, fermented ginseng and selenium-enriched yeast, and the weight percentage of fermented ginseng in the anti-aging composition is 1% to 98%, the weight percentage of selenium-enriched yeast in the anti-aging composition is 0.1% to 90%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%.

[0011] Preferably, in the anti-aging composition, the weight percentage content of fermented ginseng in the anti-aging composition is 1% to 80%, the weight percentage content of selenium-enriched yeast in the anti-aging composition is 0.5% to 60%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%.

[0012] Further preferably, in the anti-aging composition, the weight percentage content of fermented ginseng in the anti-aging composition is 10% to 65%, the weight percentage content of selenium-enriched yeast in the anti-aging composition is 1% to 45%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%.

[0013] Preferably, the anti-aging composition further comprises at least one of the following ingredients: yeast polypeptide, NMN, PQQ, taurine, astaxanthin, cystine, lutein, lycopene, polygala saponin extract, grape seed extract, honeysuckle extract, astragalus extract, schisandra extract, wolfberry polysaccharide, broken wall ganoderma lucidum spore powder, resveratrol, sea buckthorn extract, niacinamide, betaine, soy isoflavones, hesperidin, VE and VC.

[0014] Further preferably, the anti-aging composition further comprises at least one of the following ingredients: yeast polypeptide, grape seed extract, NMN, PQQ, taurine, astaxanthin, niacinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE and VC.

[0015] Still further preferably, the anti-aging composition further comprises two or more of the following ingredients: yeast polypeptide, grape seed extract, NMN, PQQ, taurine, astaxanthin, niacinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE and VC.

[0016] More preferably, the anti-aging composition further comprises a combination of yeast polypeptide and at least one of the following ingredients: grape seed extract, NMN, PQQ, taurine, astaxanthin, niacinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE and VC.

[0017] In a second aspect, the present invention provides use of the anti-aging composition in the preparation of anti-aging food or anti-aging cosmetics.

[0018] In a third aspect, the present invention provides an anti-aging food or anti-aging cosmetic, wherein the anti-aging food or anti-aging cosmetic comprises the anti-aging composition described above.

[0019] Preferably, the weight percentage of the anti-aging composition in the anti-aging food or anti-aging cosmetic is not less than 2%.

[0020] Further preferably, the weight percentage of the anti-aging composition in the anti-aging food or anti-aging cosmetic is not less than 5%.

[0021] More preferably, the weight percentage of the anti-aging composition in the anti-aging food or anti-aging cosmetic is not less than 10%.

[0022] In a fourth aspect, the present invention provides the use of the anti-aging composition in the preparation of an anti-aging preparation.

[0023] In a fifth aspect, the present invention provides an anti-aging preparation, wherein the medicine comprises the above-mentioned anti-aging composition.

[0024] Preferably, the weight percentage of the anti-aging composition in the anti-aging preparation is not less than 10%.

[0025] Preferably, the anti-aging preparations include but are not limited to oral preparations and external preparations, and the oral preparations include any one or more of tablets, capsules, oral liquids, and granules; in order to enable the preparation of the above anti-aging preparations, pharmaceutically acceptable excipients can be added when preparing these preparations.

[0026] The beneficial effects of the present invention are:

[0027] 1) The composition provided by the present invention has a good preventive effect on mitochondrial function damage and immune organ aging caused by aging. At the same time, it can enhance cell phagocytosis and the body's own antioxidant function, has a good repair effect on oxidative damage to the body, and can also downregulate inflammatory factors, and has anti-aging ability.

[0028] 2) The composition not only has a good preventive effect on internal aging of the body, but also has a certain preventive effect on skin aging, can increase the collagen fiber content of the skin, reduce the generation of wrinkles and brown spots, and improve skin microcirculation.

[0029] 3) Long-term use of the composition can resist fatigue, detoxify and protect the liver, and relieve emotional stress. DETAILED DESCRIPTION

[0030] In the description of the present invention, it should be noted that, if the specific conditions are not specified in the examples, the experiments were carried out according to conventional conditions or the conditions recommended by the manufacturer. The reagents or instruments used, if the manufacturer is not specified, are all conventional products that can be purchased commercially.

[0031] The present invention provides an anti-aging composition, which contains at least two components: fermented ginseng and selenium-enriched yeast. The weight percentage content of the fermented ginseng in the anti-aging composition is 1% to 98%, the weight percentage content of the selenium-enriched yeast in the anti-aging composition is 0.1% to 90%, and the total content of the fermented ginseng and the selenium-enriched yeast is ≤100%.

[0032] In the embodiment of the present invention, the anti-aging composition adopts fermented ginseng powder, and its preparation method refers to patent: CN 110959853 A Ginseng rare saponin composition and its preparation method and application.

[0033] In the embodiment of the present invention, the selenium content in the selenium-enriched yeast is 2 mg / g, and it is a product that has been marketed by the applicant.

[0034] Preferably, in the anti-aging composition, the weight percentage content of fermented ginseng in the anti-aging composition is 1% to 80%, the weight percentage content of selenium-enriched yeast in the anti-aging composition is 0.5% to 60%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%.

[0035] Further preferably, in the anti-aging composition, the weight percentage content of fermented ginseng in the anti-aging composition is 10% to 65%, the weight percentage content of selenium-enriched yeast in the anti-aging composition is 1% to 45%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%.

[0036] Preferably, the anti-aging composition further comprises at least one of the following ingredients: yeast polypeptide, NMN, PQQ, taurine, astaxanthin, cystine, lutein, lycopene, polygala saponin extract, grape seed extract, honeysuckle extract, astragalus extract, schisandra extract, wolfberry polysaccharide, broken wall ganoderma lucidum spore powder, resveratrol, sea buckthorn extract, niacinamide, betaine, soy isoflavones, hesperidin, VE, VC.

[0037] Further preferably, the anti-aging composition also includes at least one of the following ingredients: yeast polypeptide, grape seed extract, NMN, PQQ, taurine, astaxanthin, niacinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE, VC.

[0038] Still more preferably, the anti-aging composition further comprises two or more of the following ingredients: yeast polypeptide, grape seed extract, NMN, PQQ, taurine, astaxanthin, niacinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE, VC.

[0039] More preferably, the anti-aging composition further comprises a combination of yeast polypeptide and at least one of the following ingredients: grape seed extract, NMN, PQQ, taurine, astaxanthin, niacinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE, VC.

[0040] The present invention also provides the use of the anti-aging composition in preparing anti-aging food or anti-aging cosmetics.

[0041] The present invention also provides an anti-aging food or anti-aging cosmetic, which comprises the anti-aging composition.

[0042] Preferably, the weight percentage content of the anti-aging composition in the anti-aging food or anti-aging cosmetic is not less than 2%. Further preferably, the weight percentage content of the anti-aging composition in the anti-aging food or anti-aging cosmetic is not less than 5%. More preferably, the weight percentage content of the anti-aging composition in the anti-aging food or anti-aging cosmetic is not less than 10%, preferably 14%, and the mass ratio of the fermented ginseng powder to the selenium-enriched yeast is 1 to 2:1, preferably 1.5 to 1.8:1.

[0043] The present invention also provides the use of the anti-aging composition in preparing an anti-aging preparation.

[0044] The present invention also provides an anti-aging preparation, which comprises the anti-aging composition.

[0045] Preferably, the weight percentage of the anti-aging composition in the anti-aging preparation is not less than 10%. Further preferably, the weight percentage of the anti-aging composition in the anti-aging preparation is 14%; preferably, the mass ratio of fermented ginseng powder to selenium-enriched yeast in the medicine is 1 to 2:1, preferably 1.5 to 1.8:1.

[0046] Preferably, the anti-aging preparations include but are not limited to oral preparations and external preparations, and the oral preparations include tablets, capsules, oral liquids, and granules.

[0047] In order to realize the preparation of the drug of the present invention, pharmaceutically acceptable excipients can be added when preparing these preparations. The drug also includes pharmaceutically acceptable excipients, such as fillers, disintegrants, lubricants, suspending agents, adhesives, sweeteners, flavoring agents, preservatives, antioxidants, matrix, etc. Fillers include starch, pregelatinized starch, lactose, mannitol, chitin, microcrystalline cellulose, sucrose, etc.; disintegrants include starch, pregelatinized starch, microcrystalline cellulose, sodium carboxymethyl starch, cross-linked polyvinyl pyrrolidone, low-substituted hydroxypropyl cellulose, cross-linked sodium carboxymethyl cellulose, etc.; lubricants include magnesium stearate, sodium lauryl sulfate, talc, silicon dioxide, etc.; suspending agents include polyvinyl pyrrolidone, microcrystalline cellulose, sucrose, agar, hydroxypropyl methylcellulose, etc.; adhesives include starch slurry, polyvinyl pyrrolidone, hydroxypropyl methylcellulose, etc.; Sweeteners include: sodium saccharin, aspartame, sucrose, sodium cyclamate, glycyrrhetinic acid, etc.; flavoring agents include: sweeteners and various flavors; preservatives include: parabens, benzoic acid, sodium benzoate, sorbic acid and its salts, benzalkonium bromide, chloroethidine acetate, eucalyptus oil, etc.; antioxidants include: sodium sulfite, sodium pyrosulfite, dibutylphenol, sodium bisulfite, sodium thiosulfate, tert-butyl-p-hydroxyanisole, thiourea, vitamin C, propyl gallate, α-tocopherol, ascorbyl palmitate; matrix includes: PEG6000, PEG4000, insect wax, etc. Therefore, any other substances that are added to the drug of the present invention to help form a stable drug effect are all within the protection scope of the present invention.

[0048] The present invention is further described in detail below in conjunction with specific embodiments, which are intended to explain the present invention rather than to limit it.

[0049] The sources of the reagents used in the following examples are shown in Table 1. The reagents, instruments or operating steps not described herein are all contents that can be routinely determined by a person of ordinary skill in the art:

[0050] Table 1 Reagents used in Examples

[0051] Reagents Model / Level factory Fermented Ginseng Powder Food Grade Angel Yeast Co., Ltd. Selenium-enriched yeast Selenium content 2mg / g Angel Yeast Co., Ltd. Maltodextrin Food Grade Shandong Bailong Chuangyuan Biotechnology Co., Ltd. Vitamin E 700IU Shaanxi Haisifu Bioengineering Co., Ltd. Silicon dioxide Food Grade Shandong Jiquan Biotechnology Co., Ltd. Yeast peptides Food Grade Angel Yeast Co., Ltd.

[0052] The preparation method of yeast polypeptide refers to patent: CN115058475A A yeast polypeptide for improving exercise endurance and promoting exercise recovery and its preparation method and application.

[0053] Example 1

[0054] This embodiment provides an anti-aging preparation. The composition of the medicine is as follows, in terms of mass percentage: 13% fermented ginseng powder, 1% selenium-enriched yeast, 85% maltodextrin, and 1% silicon dioxide. The above substances are weighed according to the mass ratio, mixed evenly, and then bagged, with each bag containing 1 gram.

[0055] Example 2

[0056] The present embodiment provides an anti-aging preparation. The composition of the medicine is as follows, in terms of mass percentage: 11% fermented ginseng powder, 3% selenium-enriched yeast, 85% maltodextrin, and 1% silicon dioxide. The above substances are weighed according to the mass ratio, mixed evenly, and then packed into bags, with 1 gram per bag.

[0057] Example 3

[0058] The present embodiment provides an anti-aging preparation, which is composed of 9% fermented ginseng powder, 5% selenium-enriched yeast, 85% maltodextrin, and 1% silicon dioxide in terms of mass percentage. The above substances are weighed according to the mass ratio, mixed evenly, and filled into hard capsules, each capsule being 0.5 grams.

[0059] Example 4

[0060] The present embodiment provides an anti-aging preparation, which is composed of 7% fermented ginseng powder, 7% selenium-enriched yeast, 85% maltodextrin, and 1% silicon dioxide in terms of mass percentage. The above substances are weighed by mass, mixed evenly, and filled into hard capsules, each capsule being 0.5 grams.

[0061] Example 5

[0062] This embodiment provides an anti-aging preparation, which is composed of 6% fermented ginseng powder, 4% selenium-enriched yeast, 2% VE, 2% yeast polypeptide, 85% maltodextrin, and 1% silicon dioxide in terms of mass percentage. The mixture is evenly mixed and then packed in bags, with 1 gram per bag.

[0063] Application Example 1

[0064] 1 Animal experiments

[0065] 1.1 Test substances

[0066] The formulations in Examples 1-5 were used as test substances and fed to mice to evaluate their efficacy. The formulations of the test substances are shown in Table 2.

[0067] Table 2 Test substance formulation

[0068] Test substance Formula components (mass ratio) Test substance 1 Fermented ginseng powder 13%, selenium-enriched yeast 1%, maltodextrin 85%, silicon dioxide 1% Test substance 2 Fermented ginseng powder 11%, selenium-enriched yeast 3%, maltodextrin 85%, silicon dioxide 1% Test substance 3 Fermented ginseng powder 9%, selenium-enriched yeast 5%, maltodextrin 85%, silicon dioxide 1% Test substance 4 Fermented ginseng powder 7%, selenium-enriched yeast 7%, maltodextrin 85%, silicon dioxide 1% Test substance 5 Fermented ginseng powder 6%, selenium-enriched yeast 4%, VE 2%, yeast polypeptide 2%, maltodextrin 85%, silicon dioxide 1%

[0069] 1.2 Experimental animals

[0070] Kunming mice, male, five weeks old, weighing (20 ± 2) g, were purchased from Hubei Experimental Animal Research Center (License No.: SCXK(E)2021-0018).

[0071] 1.3 Main instruments and reagents

[0072] PB100 handheld homogenizer, Prima, UK; CT15RE desktop high-speed refrigerated centrifuge, Hitachi, Japan; multi-label microplate reader, Perkin Elmer, USA. Glutathione peroxidase (GSH-Px) kit, superoxide dismutase (SOD) kit and malondialdehyde (MDA) kit, Nanjing Jiancheng Bioengineering Institute. Lipofuscin (LF) kit, hydroxyproline (HYP) kit, type I collagen and type III collagen kit, Suzhou Calvin Biotechnology Co., Ltd.

[0073] 1.4 Animal grouping and drug administration

[0074] Fifty-six healthy Kunming male mice were randomly divided into seven groups, with eight mice in each group, namely the control group, model group, and test group (test substances 1-5 were dissolved in pure water, respectively). After three days of adaptive feeding, the test group was given a drug dose of 160 mg / kg, and the mice were given an intragastric dose of 0.1 mL / 10 g. The control group and model group were given an intragastric dose of distilled water, and the remaining groups were given an intragastric dose of the experimental dose for a total of 42 days. At the same time as the intragastric administration of each group, the control group mice were subcutaneously injected with normal saline, and the model group and the drug group mice were subcutaneously injected with D-galactose solution (200 mg / kg), once a day. Body weight was measured and recorded once a week.

[0075] 1.5 Specimen collection and index detection

[0076] After the last administration, the mice were fasted but not watered overnight, the mice were weighed, blood was collected from the eye sockets, and serum was separated. The liver tissue was removed, and the liver was homogenized with pre-cooled saline to prepare a 10% homogenate, which was centrifuged at 4°C and 5000r / min for 10min, and the supernatant was taken. The GSH-Px, SOD activity and MDA content in the mouse serum and liver homogenate were determined according to the instructions of the kit.

[0077] Skin tissue detection: The back skin of mice was depilated, and 1.5 cm × 1.5 cm back skin was taken. The subcutaneous tissue was cut off and weighed, rinsed with 0.9% NaCl solution, dried with absorbent paper, cut into pieces, added with pre-cooled 0.9% NaCl solution and appropriate amount of protein lysis buffer, and homogenized with a tissue homogenizer. The ELISA method was used to detect the contents of LF, HYP, type I collagen and type III collagen in the skin tissue.

[0078] 1.7 Data Processing

[0079] The experimental data were analyzed for significant differences using Minitab17 statistical software. The form is shown in Table 3-5.

[0080] 2 Results

[0081] Table 3 Determination results of mouse serum biochemical indicators

[0082] Grouping GSH-Px (U / mL) SOD(U / mL) MDA (μmol / L) Control group 306.47±42.09 30.47±2.04 1.21±0.11 Model Group 248.68±39.52* 21.65±6.22* 2.19±1.93* Test substance 1 255.42±20.32# 27.08±3.01# 1.56±0.47 Test substance 2 289.32±45.97# 29.77±2.15# 1.44±0.38 Test substance 3 309.28±19.10## 31.57±1.37## 1.23±0.24 Test substance 4 304.42±16.64# 30.48±1.08# 1.30±0.37 Test substance 5 310.68±20.31## 31.66±1.73## 1.11±0.45

[0083] Note: Compared with the control group, *P<0.05; compared with the model group, #P<0.05, ##P<0.01.

[0084] Table 3 shows that the relevant enzymes in the serum can reflect the body's antioxidant capacity. Compared with the control group, the GSH-Px and SOD activities in the serum of the mice in the model group were significantly reduced, and the MDA content was significantly increased, indicating that the model was successfully established. Compared with the model group, the GSH-Px and SOD activities in the serum of the five groups of subjects were increased, and the MDA content was reduced to varying degrees. Among the subjects 1 to 4, the test group 3 performed better in all aspects. At this time, the content of fermented ginseng and selenium-enriched yeast accounted for: fermented ginseng 64.3%, selenium-enriched yeast 35.7% (the total amount of fermented ginseng and selenium-enriched yeast was 100%); followed by the test group 4, the content of the two active ingredients accounted for 1:1. Test substance 5 is composed of the effective ingredients of this patent with the addition of two synergistic ingredients, VE and yeast polypeptide. From the data in the above table, it can be seen that the activities of GSH-Px and SOD in the serum of mice in this group are greatly improved, and the MDA content is significantly decreased. Compared with test substance group 3, the total amount of fermented ginseng and selenium-enriched yeast in test substance group 5 is reduced by a similar proportion, and the total amount of effective ingredients is the same. Both groups performed well in improving the activity of antioxidant-related enzymes and reducing peroxidation products, indicating that the addition of effective ingredients has a synergistic effect with the composition of the present invention.

[0085] Table 4 Determination results of mouse liver biochemical indicators

[0086] Grouping GSH-Px (U / mL) SOD(U / mL) MDA (μmol / L) Control group 454.47±41.37 80.98±10.74 7.01±5.39 Model Group 408.68±33.90* 74.99±3.10* 19.97±10.01* Test substance 1 412.42±29.04# 78.01±7.62# 15.43±8.49 Test substance 2 426.32±46.32# 79.79±4.33# 13.22±5.07 Test substance 3 479.28±31.40## 91.12±6.58## 11.01±5.62 Test substance 4 458.56±35.78# 82.01±9.33# 12.98±4.76 Test substance 5 477.37±36.55## 93.65±9.17## 10.86±6.97

[0087] Note: Compared with the control group, *P<0.05; compared with the model group, #P<0.05, ##P<0.01.

[0088] Table 4 shows that the liver is the most vulnerable place to oxidative damage and accumulation of oxidative products. The results of the biochemical index test of mouse liver are shown in Table 3. Compared with the model group, the activities of GSH-Px and SOD in the liver of the five test groups were increased, and the activity of MDA was decreased. Among the test substances 1-4, the activities of GSH-Px and SOD in the liver of the test substances 1 and 2 were significantly improved, and the effect of test substance 3 was the best. The test substance 5 with other active ingredients added had a significant effect on improving the activities of GSH-Px and SOD in the liver of mice, and the content of MDA was also significantly reduced.

[0089] Table 5 Results of determination of type I collagen, type III collagen, LF and HYP contents in mouse skin tissue

[0090]

[0091]

[0092] Note: Compared with the control group, *P<0.05; compared with the model group, #P<0.05, ##P<0.01.

[0093] Table 5 shows that aging will gradually degrade the collagen fibers contained in the skin, thereby damaging the integrity of the dermal structure. The collagen in the human dermis is mainly composed of type I collagen and type III collagen. HYP is the most important, most abundant and most stable amino acid in collagen, which can indirectly reflect the degree of dermal aging; LF is mainly deposited in the subcutaneous skin, commonly known as "age spots", and increases with age. According to the above test results, compared with the control group, the content of type I collagen, type III collagen and HYP in the skin tissue of the model group mice was significantly reduced, and the content of LF was significantly increased (P < 0.01). Compared with the model group, several groups of test substances can increase the content of type I collagen, type III collagen and HYP in the model mice, and reduce the content of LF. Among them, test substance 3 and test substance 5, which is composed of the composition of the present invention and two synergistic ingredients, yeast peptide and VE, showed better skin protection effects in the test; and according to the test results of test substances 1-5, it can be seen that the closer the addition ratio of fermented ginseng and selenium-enriched yeast in the composition of the present invention is to 3:2, the better the effect of anti-skin aging. Therefore, the composition of the present invention has the effects of inhibiting skin aging, increasing collagen fiber content, and reducing wrinkles and brown spots, and the addition of other functional ingredients has a synergistic effect.

[0094] 3 Summary

[0095] The results of the above tests on the GSH-Px, SOD activities and MDA content in the serum, liver homogenate and brain tissue homogenate of aged mice, and the LF, HYP, type I collagen and type III collagen content in the skin tissue show that the composition of the present invention has a significant anti-aging effect on aged mice, can enhance the body's antioxidant capacity, protect the body from oxidative damage, and can improve the collagen content in the skin of aged mice, reduce wrinkles and age spots, and its main mechanism may be related to enhancing cell phagocytosis and the body's own antioxidant capacity and promoting collagen repair in the body.

[0096] Application Example 2

[0097] 1 Animal experiments

[0098] 1.1 Test substances

[0099] The anti-aging preparation of Example 3 was selected as the test substance of this experiment.

[0100] 1.2 Experimental animals

[0101] Thirty-two 11-month-old female aged mice and eight 8-week-old young mice, weighing (25 ± 5) g, were purchased from Hubei Experimental Animal Research Center (License No.: SCXK(E)2021-0018).

[0102] 1.3 Main instruments and reagents

[0103] UV spectrophotometer (Amersham Biosciences); cell ultrasonic crusher (VCX130PB, SONICS Corporation); adenosine triphosphate (ATP) bioluminescence detection kit (Sigma, batch number: 20180125), follicular estrogen receptor antibody and human chorionic gonadotropin hCG (Sigma, batch number: 20180116); respiratory chain complex detection kit (Ab-cam, Ab203412, ab110926, ab118810, ab109827).

[0104] 1.4 Animal grouping and drug administration

[0105] The subjects were divided into a young control group, an aging blank control group, and a fermented ginseng selenium-enriched yeast (low 80 mg / kg, medium 160 mg / kg, and high 320 mg / kg) group. The experimental group was given intragastric administration at a dose of 0.1 ml / 10 g, once a day, for 60 consecutive days. The young group and the elderly control group were given an equal volume of normal saline.

[0106] 1.5 Specimen collection and index detection

[0107] Preparation of mouse ovarian granulosa cells: After the end of the medication, each mouse was intraperitoneally injected with human chorionic gonadotropin (hCG) (8U-10U). After 48 hours, the mice were killed by cervical dislocation, disinfected with iodine and alcohol, and the ovaries were quickly placed in pre-cooled PBS under sterile conditions, washed three times, and other tissues were carefully shaved. Under a dissecting microscope, the follicles were punctured with a 1mL syringe needle to release the granulosa cells into the DMEM culture medium. The cells were broken up in a centrifuge tube, digested with 0.25% trypsin, filtered with a stainless steel sieve with a pore size of 0.074mm, centrifuged at 1000r / min for 5min, and the cells were collected and used after identification.

[0108] ATP content determination: ATP content was detected using a bioluminescence detection kit. According to the instructions of the kit, 1×10 4 For each pellet of cells, lyse the cells with 100 μl of lysis buffer, add diluent at a ratio of 1:5, and leave at room temperature for 5 minutes. Take out 200 μl, add 100 μl of pre-cooled ultrapure water, and mix. Take 250 μl to measure the absorbance. Calculate the ATP concentration according to the standard curve.

[0109] Detection of mitochondrial respiratory chain complex activity: follow the instructions of the relevant kit. Extract mitochondria: lyse cells with pre-cooled tissue lysis buffer, centrifuge at 1000r / min, 4℃ for 5min, take the supernatant, centrifuge at 12000r / min, 4℃ for 10min, discard the supernatant, collect the precipitate to obtain mitochondria. When measuring, adjust the mitochondrial protein concentration of the sample to 100μg / ml, add the corresponding reagent, measure complex I at 340nm, measure complex II at 600nm, measure complex III at 550nm, and measure complex IV at 550nm.

[0110] 1.7 Data Processing

[0111] The experimental data were analyzed for significant differences using Minitab17 statistical software. The form is shown in Table 6-7.

[0112] 2 Results

[0113] 2.1 ATP content in ovarian granulosa cells

[0114] Table 6 Results of ATP content determination in mouse ovarian granulosa cells

[0115] Grouping Dosage (mg / kg) <![CDATA[ATP(μmol / 10 4 cell)]]> Youth control group — 956±86** Elderly control group — 409±23 Low-dose group of fermented ginseng selenium-enriched yeast 80 587±33* Medium dose group of fermented ginseng selenium-enriched yeast 160 654±47** Fermented ginseng selenium-enriched yeast high-dose group 320 667±69**

[0116] Note: *P<0.05, **P<0.01 compared with the elderly control group

[0117] Table 6 shows that, whether human or other animals, there is a phenomenon of decreased ATP synthesis in aged ovarian cells, so the amount of ATP is an important indicator of mitochondrial function. Through the test data results, it was found that compared with young mice, the ATP in the ovarian granulosa cells of old mice decreased significantly, while the ATP content in the cells of the aged mice in the low-dose group of fermented ginseng selenium-enriched yeast of the present invention was significantly increased compared with the elderly control group (P < 0.05), the ATP content in the cells of the aged mice in the medium-dose group was significantly increased, increased by 59.9%, and the ATP content in the cells of the aged mice in the high-dose group of fermented ginseng selenium-enriched yeast was also significantly increased, but only increased by 2.0% compared with the medium-dose group, indicating that the composition of the present invention has an improvement effect on the decline in mitochondrial function caused by aging.

[0118] 2.2 Activity of respiratory chain complexes in ovarian granulosa cells

[0119] Table 7 Results of the activity assay of respiratory chain complexes in mouse ovarian granulosa cells

[0120]

[0121] Note: *P<0.05, **P<0.01 compared with the elderly control group

[0122] Table 7 shows that in the development process of ovarian follicles, the synthesis of various substances, the secretion of hormones and other functional activities require a lot of energy, and most of this energy comes from the aerobic oxidation of mitochondria in cells. The activity of the respiratory chain complex of cells can show mitochondrial function. From the data results, it can be seen that compared with young mice, the mitochondrial respiratory activity of ovarian granulosa cells in the elderly control group mice decreased significantly. Compared with the elderly control group, the various respiratory chain complexes in the low-dose group of fermented ginseng selenium-enriched yeast have recovered to varying degrees, among which the activities of complex I and complex III are significantly increased, indicating that the composition of the present invention has an improvement effect on the mitochondrial respiratory function caused by aging, and the medium and high dose groups have better effects than the low dose group.

[0123] 3 Summary

[0124] The above results of measuring the number of ATP in mouse ovarian cells and the activity of the respiratory chain complex of ovarian granulosa cells show that the composition of the present invention has a significant improvement effect on mitochondrial damage in aging mice, and the two compositions of the present invention show a strong synergistic anti-aging effect.

[0125] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the patent of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. An anti-aging composition, Features: The anti-aging composition contains at least two active ingredients, namely, fermented ginseng and selenium-enriched yeast, wherein the weight percentage of fermented ginseng in the anti-aging composition is 1% to 98%, the weight percentage of selenium-enriched yeast in the anti-aging composition is 0.1% to 90%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%.

2. An anti-aging composition according to claim 1, Features: In the anti-aging composition, the weight percentage content of fermented ginseng in the anti-aging composition is 1% to 80%, the weight percentage content of selenium-enriched yeast in the anti-aging composition is 0.5% to 60%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%; further preferably, in the anti-aging composition, the weight percentage content of fermented ginseng in the anti-aging composition is 10% to 65%, the weight percentage content of selenium-enriched yeast in the anti-aging composition is 1% to 45%, and the total content of fermented ginseng and selenium-enriched yeast is ≤100%.

3. An anti-aging composition according to claim 1 or 2, Features: The anti-aging composition also includes at least one of the following ingredients: yeast polypeptide, NMN, PQQ, taurine, astaxanthin, cystine, lutein, lycopene, polygala saponin extract, grape seed extract, honeysuckle extract, astragalus extract, schisandra extract, wolfberry polysaccharide, broken wall ganoderma lucidum spore powder, resveratrol, sea buckthorn extract, niacinamide, betaine, soy isoflavones, hesperidin, VE and VC.

4. An anti-aging composition according to claim 3, Features: The anti-aging composition further comprises at least one of the following ingredients: yeast polypeptide, grape seed extract, NMN, PQQ, taurine, astaxanthin, nicotinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE and VC; further preferably, the anti-aging composition further comprises two or more of the following ingredients: yeast polypeptide, grape seed extract, NMN, PQQ, taurine, astaxanthin, nicotinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE and VC; more preferably, the anti-aging composition further comprises a combination of yeast polypeptide and at least one of the following ingredients: grape seed extract, NMN, PQQ, taurine, astaxanthin, nicotinamide, cystine, resveratrol, soy isoflavones, hesperidin, VE and VC.

5. Use of the anti-aging composition according to any one of claims 1 to 4 in the preparation of anti-aging food.

6. An anti-aging food or anti-aging cosmetic, Features: The anti-aging food or anti-aging cosmetic comprises the anti-aging composition according to any one of claims 1 to 4.

7. The anti-aging food or anti-aging cosmetic according to claim 6, Features: The weight percentage content of the anti-aging composition in anti-aging food or anti-aging cosmetics is not less than 2%; preferably, the weight percentage content of the anti-aging composition in anti-aging food or anti-aging cosmetics is not less than 5%; more preferably, the weight percentage content of the anti-aging composition in anti-aging food or anti-aging cosmetics is not less than 10%.

8. Use of the anti-aging composition according to any one of claims 1 to 4 in the preparation of anti-aging preparations.

9. An anti-aging preparation, Features: The medicine comprises the anti-aging composition according to any one of claims 1 to 4.

10. The anti-aging preparation according to claim 9, Features: The weight percentage of the anti-aging composition in the anti-aging preparation is not less than 10%.

11. The anti-aging preparation according to claim 9, Features: The anti-aging preparation includes oral preparations and external preparations. The oral preparation includes any one or more of tablets, capsules, oral liquids and granules. Preferably, the medicine also includes pharmaceutically acceptable excipients.

Citation Information

Cited By

  • Microbial stabilizer as well as preparation method and application thereof

    CN120210034A

  • Cosmetic composition for skin cell longevity

    WO2026139326A1